Significant immunological abnormalities (54), including as CD4 lymphopenia (55), elevated regulatory T cell percentages in peripheral blood, and changes in cytokine profiles from Th1 to Th2 (56), are present in glioma patients. The gene discussed is CD4; the disease is central nervous system cancer.